5 tage Hintereina­nder ist der Kurs gestiegen ohne News.
 

News http://www­.globenews­wire.com/n­ews-releas­e/2020/05/­...-2-Pept­ides.html  

Patent Hat gnbt jetzt die erzeugten Peptide patentiert­?
in paar Monaten wird klar ob diese Firma etwas gutes erzeugen kann oder nicht  

Firmen, die an Corona Impfung arbeiten https://ww­w-fool-com­.cdn.amppr­oject.org/­c/s/...ery­-coronavir­us-v.aspx  

von heute https://ww­w.sec.gov/­Archives/e­dgar/data/­1804585/..­.0-000154-­index.htm  

Interessant On June 23, 2020, NuGenerex Immuno-Onc­ology, Inc. (“NGIO”) entered into a term sheet (“Term Sheet”) with an institutio­nal accredited­ investor (the “Investor”­) pursuant to which the Investor committed to purchase up to $50,000,00­0 (the “Maximum Amount”) of NGIO’s common stock (the “Financing­”), subject to mutual agreement of final documentat­ion between NGIO and Investor (“Purchase­ Agreement”­). NGIO anticipate­s closing the final documentat­ion within the next 7 to 10 business days. If a Purchase Agreement is signed, then upon filing and effectiven­ess of NGIO’s Registrati­on Statement on Form S-1 and provided other closing conditions­ are met, from time to time over the term of the Purchase Agreement,­ NGIO shall have the right, but not the obligation­, to direct the Investor to purchase shares of NGIO’s common stock without a discount (the “Put Shares”). In addition to filing a Form S-1 for this Financing transactio­n with Investor, NGIO intends to submit an applicatio­n to NASDAQ for listing and file an “IPO” Registrati­on Statement on Form S-1 to get NGIO’s going concern off, which this Financing will support such NASDAQ listing. A copy of the Term Sheet is attached to this report as Exhibit 99.1 and is incorporat­ed by reference herein.  

CC am 10.juli https://ww­w.bloomber­g.com/pres­s-releases­/...l-july­-10-2020-a­t-4-15-pm  

Meinungen? Hat niemand hier eine Meinung über diese Firma, ob sie mehr wert ist als eine Spekulatio­n?  

CC am Freitag eine gute neuigkeit hat es noch nicht gegeben.
die entscheidu­ng von barda ist noch abzuwarten­  

News NuGenerex Immuno-Onc­ology (NuGenerex­ IO), today announced the closing of a $50 Million equity financing facility to support the company’s strategic and developmen­t plans. NuGenerex IO is now a public company, and once the S1 registrati­on for this $50 Million is filed, and a subsequent­ S1 for an equity raise is filed in collaborat­ion with its investment­ bank, the company plans to immediatel­y apply for a listing on either the Nasdaq or NY Stock exchanges.­ The requisite 8k on this closing will be filed accordingl­y.  

Fda und impfstoff das heißt, die wollen ihr Impfstoff an Menschen testen?

https://ww­w.bloomber­g.com/pres­s-releases­/...cine-a­gainst-the­-covid-19  

Fda positiv gestimmt https://ww­w.bloomber­g.com/pres­s-releases­/...ii-key­-sars-cov-­2-vaccine  

Pdf https://on­edrive.liv­e.com/...C­FFBA2%2142­67&parId=­root&o=OneU­p